91 results
8-K/A
EX-99.2
LSTA
Lisata Therapeutics Inc
4 Oct 22
Other Events
4:42pm
, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping … , interruption or other issues that arise in the manufacture, fill-finish, packaging, or storage of Cend’s precision medicines as a result of a failure
424B3
LSTA
Lisata Therapeutics Inc
29 Jul 22
Prospectus supplement
4:06pm
manufacturing changes, packaging, storage, recordkeeping, labeling, advertising and promotion, distribution, marketing, import and export … .
Facilities engaged in the recovery, processing, storage, labeling, packaging or distribution of any human cells, tissues or cellular- and tissue-based
8-K
EX-10.1
dx9ix5fk kwudr
4 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-10.1
w240v73bk0o84
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.1
nm6d 8hc1
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
mkmab8989 mcip
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.1
gclg zu0k3ukwpcdo
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm